January 07, 2009
Gilead Sciences to Present at the 27th Annual JPMorgan Healthcare Conference on Monday, January 12
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 7, 2009--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate
presentation will be webcast from the 27th Annual JPMorgan
Healthcare Conference in San Francisco.
John Martin, PhD, Gilead's Chairman and Chief Executive Officer, will
provide an overview of the company on Monday, January 12 at 2:30 p.m.
Pacific Time (5:30 p.m. Eastern Time).
To access the live webcast via the internet log on to www.gilead.com.
Please connect to the company's website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company's mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)
Source: Gilead Sciences, Inc.